Factors associated with chloroquine-induced retinopathy in rheumatic diseases: comments on the article by Araiza-Casillas et al.
Michael
M
Easterbrook
D000962:Antimalarials / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001827:Body Height; D001835:Body Weight; D002738:Chloroquine / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D012164:Retinal Diseases / Q000139:chemically induced*; D012216:Rheumatic Diseases / Q000188:drug therapy*; D012307:Risk Factors
D000962:Antimalarials; D018501:Antirheumatic Agents; D002738:Chloroquine